PetMed Express Inc (PETS) - Net Assets
Based on the latest financial reports, PetMed Express Inc (PETS) has net assets worth $28.94 Million USD as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($81.19 Million) and total liabilities ($52.25 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check PETS strategic asset allocation to assess the company's strategic physical and investment asset allocation.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $28.94 Million |
| % of Total Assets | 35.64% |
| Annual Growth Rate | 11.7% |
| 5-Year Change | -79.52% |
| 10-Year Change | -65.21% |
| Growth Volatility | 64.69 |
PetMed Express Inc - Net Assets Trend (2000–2026)
This chart illustrates how PetMed Express Inc's net assets have evolved over time, based on quarterly financial data. For live market cap and overall valuation, see PETS company net worth.
Annual Net Assets for PetMed Express Inc (2000–2026)
The table below shows the annual net assets of PetMed Express Inc from 2000 to 2026. Also explore net asset momentum of PetMed Express Inc to track the company's year-over-year net asset growth rate.
| Year | Net Assets | Change |
|---|---|---|
| 2026-03-31 | $28.94 Million | -70.08% |
| 2024-03-31 | $96.73 Million | -12.04% |
| 2023-03-31 | $109.97 Million | -22.66% |
| 2022-03-31 | $142.19 Million | +0.64% |
| 2021-03-31 | $141.28 Million | +8.67% |
| 2020-03-31 | $130.01 Million | -3.47% |
| 2019-03-31 | $134.68 Million | +16.37% |
| 2018-03-31 | $115.73 Million | +23.95% |
| 2017-03-31 | $93.37 Million | +12.23% |
| 2016-03-31 | $83.19 Million | +10.29% |
| 2015-03-31 | $75.44 Million | +7.43% |
| 2014-03-31 | $70.22 Million | +9.69% |
| 2013-03-31 | $64.01 Million | -21.15% |
| 2012-03-31 | $81.18 Million | -16.31% |
| 2011-03-31 | $97.00 Million | +0.15% |
| 2010-03-31 | $96.86 Million | +29.20% |
| 2009-03-31 | $74.97 Million | +11.84% |
| 2008-03-31 | $67.03 Million | +24.45% |
| 2007-03-31 | $53.86 Million | +43.10% |
| 2006-03-31 | $37.64 Million | +55.43% |
| 2005-03-31 | $24.22 Million | +73.05% |
| 2004-03-31 | $13.99 Million | +150.23% |
| 2003-03-31 | $5.59 Million | +253.36% |
| 2002-03-31 | $1.58 Million | +109.00% |
| 2001-03-31 | $757.29K | -53.56% |
| 2000-03-31 | $1.63 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to PetMed Express Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 1223314900.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (March 2026)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | $9.26 Million | 32.01% |
| Common Stock | $21.00K | 0.07% |
| Other Components | $19.66 Million | 67.92% |
| Total Equity | $28.94 Million | 100.00% |
PetMed Express Inc Competitors by Market Cap
The table below lists competitors of PetMed Express Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
AKKO Invest Nyrt
BUD:AKKO
|
$34.64 Million |
|
3S KOREA Co. Ltd
KQ:060310
|
$34.65 Million |
|
Willowglen MSC Bhd
KLSE:0008
|
$34.65 Million |
|
Dimension Computer Technology Co Ltd
TWO:6140
|
$34.68 Million |
|
Jack Chia Industries (Thailand) Public Company Limited
BK:JCT
|
$34.61 Million |
|
Generations Bancorp NY Inc
NASDAQ:GBNY
|
$34.60 Million |
|
Kafein Yazilim
IS:KFEIN
|
$34.59 Million |
|
Central Petroleum Ltd
AU:CTP
|
$34.58 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in PetMed Express Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2026, total equity changed from 96,731,000 to 28,940,000, a change of -67,791,000 (-70.1%).
- Net loss of 57,286,000 reduced equity.
- Dividend payments of 21,000 reduced retained earnings.
- Other factors decreased equity by 10,484,000.
Equity Change Factors (2024 to 2026)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-57.29 Million | -197.95% |
| Dividends Paid | $21.00K | -0.07% |
| Other Changes | $-10.48 Million | -36.23% |
| Total Change | $- | -70.08% |
Book Value vs Market Value Analysis
This analysis compares PetMed Express Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.17x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 6.33x to 1.17x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2000-03-31 | $0.26 | $1.62 | x |
| 2001-03-31 | $0.08 | $1.62 | x |
| 2002-03-31 | $0.08 | $1.62 | x |
| 2003-03-31 | $0.27 | $1.62 | x |
| 2004-03-31 | $0.59 | $1.62 | x |
| 2005-03-31 | $1.02 | $1.62 | x |
| 2006-03-31 | $1.55 | $1.62 | x |
| 2007-03-31 | $2.22 | $1.62 | x |
| 2008-03-31 | $2.76 | $1.62 | x |
| 2009-03-31 | $3.19 | $1.62 | x |
| 2010-03-31 | $4.26 | $1.62 | x |
| 2011-03-31 | $4.28 | $1.62 | x |
| 2012-03-31 | $3.92 | $1.62 | x |
| 2013-03-31 | $3.19 | $1.62 | x |
| 2014-03-31 | $3.50 | $1.62 | x |
| 2015-03-31 | $3.75 | $1.62 | x |
| 2016-03-31 | $4.11 | $1.62 | x |
| 2017-03-31 | $4.58 | $1.62 | x |
| 2018-03-31 | $5.66 | $1.62 | x |
| 2019-03-31 | $6.57 | $1.62 | x |
| 2020-03-31 | $6.48 | $1.62 | x |
| 2021-03-31 | $7.02 | $1.62 | x |
| 2022-03-31 | $6.98 | $1.62 | x |
| 2023-03-31 | $5.41 | $1.62 | x |
| 2024-03-31 | $4.74 | $1.62 | x |
| 2026-03-31 | $1.38 | $1.62 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently PetMed Express Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -197.95%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -32.00%
- • Asset Turnover: 2.20x
- • Equity Multiplier: 2.81x
- Recent ROE (-197.95%) is below the historical average (-2.82%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2000 | -110.02% | -12.22% | 2.32x | 3.88x | $-1.96 Million |
| 2001 | -373.27% | -28.25% | 2.22x | 5.95x | $-2.90 Million |
| 2002 | 52.15% | 2.58% | 6.88x | 2.94x | $667.14K |
| 2003 | 58.25% | 5.93% | 6.09x | 1.61x | $2.70 Million |
| 2004 | 41.54% | 6.19% | 5.09x | 1.32x | $4.41 Million |
| 2005 | 33.08% | 7.39% | 3.85x | 1.16x | $5.59 Million |
| 2006 | 32.05% | 8.77% | 3.23x | 1.13x | $8.30 Million |
| 2007 | 26.81% | 8.90% | 2.65x | 1.14x | $9.06 Million |
| 2008 | 29.87% | 10.63% | 2.56x | 1.10x | $13.32 Million |
| 2009 | 30.65% | 10.47% | 2.68x | 1.09x | $15.48 Million |
| 2010 | 26.85% | 10.91% | 2.29x | 1.08x | $16.32 Million |
| 2011 | 21.52% | 9.01% | 2.18x | 1.10x | $11.17 Million |
| 2012 | 20.52% | 6.99% | 2.62x | 1.12x | $8.54 Million |
| 2013 | 26.81% | 7.53% | 3.11x | 1.14x | $10.76 Million |
| 2014 | 25.59% | 7.70% | 2.98x | 1.12x | $10.95 Million |
| 2015 | 23.14% | 7.61% | 2.77x | 1.10x | $9.91 Million |
| 2016 | 24.72% | 8.76% | 2.60x | 1.09x | $12.25 Million |
| 2017 | 25.51% | 9.56% | 2.21x | 1.21x | $14.48 Million |
| 2018 | 32.22% | 13.62% | 2.03x | 1.17x | $25.71 Million |
| 2019 | 28.02% | 13.32% | 1.84x | 1.15x | $24.27 Million |
| 2020 | 19.88% | 9.10% | 1.83x | 1.19x | $12.85 Million |
| 2021 | 16.93% | 7.88% | 1.62x | 1.33x | $9.79 Million |
| 2022 | 14.84% | 7.72% | 1.55x | 1.24x | $6.88 Million |
| 2023 | 4.67% | 2.00% | 1.51x | 1.55x | $-5.86 Million |
| 2024 | -7.72% | -2.72% | 1.61x | 1.76x | $-17.14 Million |
| 2026 | -197.95% | -32.00% | 2.20x | 2.81x | $-60.18 Million |
Industry Comparison
This section compares PetMed Express Inc's net assets metrics with peer companies in the Pharmaceutical Retailers industry.
Industry Context
- Industry: Pharmaceutical Retailers
- Average net assets among peers: $2,927,170,144
- Average return on equity (ROE) among peers: -73.98%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| PetMed Express Inc (PETS) | $28.94 Million | -110.02% | 1.81x | $34.62 Million |
| Bimi International Medical Inc (BIMI) | $9.99 Million | -168.11% | 1.31x | $6.98K |
| High Tide Inc (HITI) | $-9.66 Million | 0.00% | 0.00x | $204.80 Million |
| Trxade Group Inc (MEDS) | $3.77 Million | -109.09% | 0.53x | $2.84 Million |
| POMDOCTOR LIMITED American Depositary Shares (POM) | $-481.30 Million | 0.00% | 0.00x | $5.11 Million |
| Ridgetech, Inc. (RDGT) | $38.15 Million | -37.57% | 0.78x | $2.96 Million |
| Scienture Holdings, Inc. (SCNX) | $668.44K | -301.01% | 0.83x | $13.92 Million |
| SunLink Health Systems Inc (SSY) | $33.74 Million | 13.30% | 1.02x | $7.85 Million |
| Walgreens Boots Alliance Inc (WBA) | $23.82 Billion | 10.67% | 2.41x | $10.37 Billion |
About PetMed Express Inc
PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional suppleme… Read more